XML 32 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)
1 Months Ended 3 Months Ended
Dec. 22, 2017
Mar. 30, 2016
Dec. 31, 2017
Dec. 31, 2016
Sep. 30, 2017
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Textual)          
Common stock, shares issued     9,975,518    
Common stock warrants outstanding     9,975,518   8,345,844
Common stock options value outstanding     $ 9,976   $ 8,346
Goodwill     1,586,796   $ 1,586,796
Research and development     $ 606,521 $ 1,411,159  
Maximum [Member]          
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Textual)          
U.S. corporate tax rate 35.00%        
Minimum [Member]          
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Textual)          
U.S. corporate tax rate 21.00%        
Acquisition of Leonard-Meron Biosciences, Inc. [Member]          
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Textual)          
Common stock, shares issued   1,942,456      
Issued and outstanding common stock   41.00%      
Common stock warrants outstanding   243,020      
Common stock options outstanding   77,252      
Intangible assets   $ 19,400,000      
Common stock options value outstanding   19,015,073      
Estimated fair value   17,482,093      
Estimated fair value warrant issued   1,071,172      
Estimated vested options of fair value   461,808      
Goodwill   1,586,796      
Purchase price   19,015,073      
Assets acquired   $ 17,428,277